Skip to main content

Table 2 Evaluation of association between GRPR broncial expression and demographic and risk factors stratified by lung cancer case status.

From: Gastrin-releasing peptide receptor expression in non-cancerous bronchial epithelia is associated with lung cancer: a case-control study

 

Lung Cancer Cases

Controls

Characteristic

Total

GRPR Positive

GRPR Negative

P

Total

GRPR Positive

GRPR Negative

P

N

224

158

70.5%

66

29.5%

 

107

41

38.3%

66

61.7%

 

Age

            

   Median (Range)

224

67 (42-84)

70 (41-85)

0.01*†

 

52 (31-80)

52 (31-83)

0.44†

Sex

            

   Male

105

75

71.4%

30

28.6%

0.78‡

60

20

33.3%

40

66.7%

0.23‡

   Female

119

83

69.7%

36

30.3%

 

47

21

44.7%

26

55.3%

 

Ethnicity

            

   Caucasian

213

150

70.4%

63

29.6%

1.00§

101

38

37.6%

63

62.4%

0.67§

   Non-Caucasian

10

7

70.0%

3

30.0%

 

6

3

50.0%

3

50.0%

 

Smoking Status

            

   Never Smoker

19

17

89.5%

2

10.5%

0.03*§

33

11

33.3%

22

66.7%

0.02*§

   Former Smoker

111

70

63.1%

41

36.9%

 

57

18

31.6%

39

68.4%

 

   Active Smoker

87

65

74.7%

22

25.3%

 

14

10

71.4%

4

28.6%

 

Pulmonary Function

            

   Normal

89

62

69.7%

27

30.3%

0.52§

36

18

50.0%

18

50.0%

0.22§

   Mild Obstruction

14

9

64.3%

5

35.7%

 

5

2

40.0%

3

60.0%

 

   Moderate Obstruction

52

37

71.2%

15

28.8%

 

16

5

31.3%

11

68.8%

 

   Severe Obstruction

37

30

81.1%

7

18.9%

 

46

13

28.3%

33

71.7%

 

Pack-Years

            

   Median (Range)

222

50 (0-150)

50 (0-120)

0.94†

 

40 (0-110)

25 (0-156)

0.11†

Disease Stage

            

   CIS

1

1

100.0%

0

0.0%

0.49§

-

-

 

-

 

-

   1

98

69

70.4%

29

29.6%

 

-

-

 

-

  

   2

38

24

63.2%

14

36.8%

 

-

-

 

-

  

   3

49

39

79.6%

10

20.4%

 

-

-

 

-

  

   4

16

11

68.8%

5

31.3%

 

-

-

 

-

  

Histology

            

   Adenocarcinoma

112

74

66.1%

38

33.9%

0.50§

-

-

 

-

 

-

   Squamous cell carcinoma

60

47

78.3%

13

21.7%

 

-

-

 

-

  

   Other NSCLC

27

19

70.4%

8

29.6%

 

-

-

 

-

  

   Small cell lung cancer

10

8

80.0%

2

20.0%

 

-

-

 

-

  

   Other/unknown

15

10

66.7%

5

33.3%

 

-

-

 

-

  
  1. *Significant at P < 0.05
  2. † Wilcoxon rank sum test
  3. ‡ Chi-square test
  4. § Fisher's exact test